SCHEMBL26080447

SCHEMBL26080447

c1ccc(-c2cccc(-c3ccccc3-c3nc(-c4ccc5c(c4)sc4ccccc45)nc(-c4ccc5sc6ccccc6c5c4)n3)c2)cc1

nearest known ligand 0.40

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
PIM3 Q86V86 2/20 0.40
ALOX5 P09917 1/20 0.38
ALDH1A1 P00352 1/20 0.36
MAPT P10636 1/20 0.36
HPGD P15428 1/20 0.36
RAB9A P51151 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
LIMK1 P53667 2/20 0.36
PIK3CA P42336 1/20 0.35
PI4KA P42356 1/20 0.35
PI4KB Q9UBF8 1/20 0.35
F9 P00740 2/20 0.35
MAP3K8 P41279 3/20 0.34
CYP1A2 P05177 1/20 0.34
ROCK1 Q13464 1/20 0.34
GPR3 P46089 1/20 0.34
MCL1 Q07820 1/20 0.33
PIM1 P11309 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26080563 0.97 PIM3 (0.41) PIM3ALOX5LIMK1PIK3CAPI4KA
SCHEMBL26193972 0.96 PIM3 (0.41) PIM3ALOX5ALDH1A1MAPTHPGD
SCHEMBL26193844 0.96 PIM3 (0.41) PIM3ALOX5ALDH1A1MAPTHPGD
SCHEMBL26193843 0.96 PIM3 (0.41) PIM3ALOX5ALDH1A1MAPTHPGD
SCHEMBL25852078 0.95 ALOX5 (0.39) PIM3ALOX5ALDH1A1MAPTHPGD
SCHEMBL26080450 0.94 PIM3 (0.40) PIM3ALOX5ALDH1A1MAPTHPGD
SCHEMBL23027546 0.94 F9 (0.40) PIM3ALOX5ALDH1A1MAPTHPGD
SCHEMBL23027553 0.94 F9 (0.40) PIM3ALOX5ALDH1A1MAPTHPGD
SCHEMBL22240594 0.93 PIM3 (0.40) PIM3ALOX5ALDH1A1MAPTHPGD
SCHEMBL22352511 0.93 PIM3 (0.38) PIM3ALOX5ALDH1A1MAPTHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230312538-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LT MATERIALS CO., LTD. (KR) 2023-10-05 US disclosed
US-20230312538-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LT MATERIALS CO., LTD. (KR) 2023-10-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230312538-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME CRY1, CYP1A1, CYP1B1 PIM3 2808/4885ALOX5 579/4885ALDH1A1 18/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.